JOHN FLAVIN - 24 Mar 2023 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
Director
Signature
/s/ Pamela Connealy, Attorney-in-Fact for John Flavin
Issuer symbol
PYXS
Transactions as of
24 Mar 2023
Transactions value $
$0
Form type
4
Filing time
28 Mar 2023, 16:43:00 UTC
Previous filing
04 Apr 2022
Next filing
28 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PYXS Common Stock Award $0 +139K +58.44% $0.00 378K 24 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.